CRISPR technology has the potential to transform medicine, science and beyond. Yet genome editing also faces myriad challenges: scientific, political and ethical. It may still be decades before genome editing is reliable, affordable and morally defensible – and accepted by the public. Kevin Davies’ book elegantly weaves in the competition and conflict surrounding the discovery, development and explosion in CRISPR applications with the very serious moral and societal questions inevitably raised.
About the Author
Kevin Davies is the executive editor of The CRISPR Journal and the founding editor of Nature Genetics. He is the author of Cracking the Genome and The $1,000 Genome.
Comment on this summary
By the same author
In our Journal
2 years ago
Our Favorite Books of 2020
Even a messed-up year can produce fantastic new releases. Here, getAbstract team members share their summary favorites. Many people had more time to read this year (than perhaps they wanted to). At getAbstract, the demand for new books was so great that each of us had to work a few night shifts and go the […]